# Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle

> **NCT00971152** · PHASE3 · COMPLETED · sponsor: **Clinique Ovo** · enrollment: 366 (actual)

## Conditions studied

- Subfertility

## Interventions

- **DRUG:** menotropins for injection
- **DRUG:** urofollitropin for injection

## Key facts

- **NCT ID:** NCT00971152
- **Lead sponsor:** Clinique Ovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-10
- **Final completion:** 2014-02
- **Target enrollment:** 366 (ACTUAL)
- **Last updated:** 2014-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971152, "Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00971152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*